Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 微生物學科所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26506
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor蔡錦華(Ching-Hwa Tsai)
dc.contributor.authorJiou-Cun Tsaien
dc.contributor.author蔡久存zh_TW
dc.date.accessioned2021-06-08T07:12:54Z-
dc.date.copyright2008-09-11
dc.date.issued2008
dc.date.submitted2008-07-29
dc.identifier.citationAdamson, A.L., and Kenney, S. (1999). The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. Journal of virology 73, 6551-6558.
Allen, S.M., Florell, S.R., Hanks, A.N., Alexander, A., Diedrich, M.J., Altieri, D.C., and Grossman, D. (2003). Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Cancer research 63, 567-572.
Altieri, D.C. (2008). Survivin, cancer networks and pathway-directed drug discovery. Nature reviews 8, 61-70.
Ambrosini, G., Adida, C., and Altieri, D.C. (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature medicine 3, 917-921.
Andersson-Anvret, M., Forsby, N., Klein, G., Henle, W., and Biorklund, A. (1979). Relationship between the Epstein-Barr virus genome and nasopharyngeal carcinoma in Caucasian patients. International journal of cancer 23, 762-767.
Baer, R., Bankier, A.T., Biggin, M.D., Deininger, P.L., Farrell, P.J., Gibson, T.J., Hatfull, G., Hudson, G.S., Satchwell, S.C., Seguin, C., and et al. (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-211.
Baumann, M., Mischak, H., Dammeier, S., Kolch, W., Gires, O., Pich, D., Zeidler, R., Delecluse, H.J., and Hammerschmidt, W. (1998). Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation. Journal of virology 72, 8105-8114.
Borbely, A.A., Murvai, M., Konya, J., Beck, Z., Gergely, L., Li, F., and Veress, G. (2006). Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. The Journal of general virology 87, 287-294.
Bornkamm, G.W., Hudewentz, J., Freese, U.K., and Zimber, U. (1982). Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region. Journal of virology 43, 952-968.
Burgstahler, R., Kempkes, B., Steube, K., and Lipp, M. (1995). Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2. Biochemical and biophysical research communications 215, 737-743.
Calender, A., Billaud, M., Aubry, J.P., Banchereau, J., Vuillaume, M., and Lenoir, G.M. (1987). Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America 84, 8060-8064.
Cayrol, C., and Flemington, E.K. (1995). Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1. Journal of virology 69, 4206-4212.
Chai, J., Shiozaki, E., Srinivasula, S.M., Wu, Q., Datta, P., Alnemri, E.S., and Shi, Y. (2001). Structural basis of caspase-7 inhibition by XIAP. Cell 104, 769-780.
Chang, L.K., and Liu, S.T. (2000). Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. Nucleic acids research 28, 3918-3925.
Chang, Y., Lee, H.H., Chen, Y.T., Lu, J., Wu, S.Y., Chen, C.W., Takada, K., and Tsai, C.H. (2006). Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta. Journal of virology 80, 7748-7755.
Cochet, C., Martel-Renoir, D., Grunewald, V., Bosq, J., Cochet, G., Schwaab, G., B ernaudin, J.F., and Joab, I. (1993). Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 197, 358-365.
Connell, C.M., Colnaghi, R., and Wheatley, S.P. (2008). Nuclear survivin has reduced stability and is not cytoprotective. The Journal of biological chemistry 283, 3289-3296.
Cordier, M., Calender, A., Billaud, M., Zimber, U., Rousselet, G., Pavlish, O., Banchereau, J., Tursz, T., Bornkamm, G., and Lenoir, G.M. (1990). Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. Journal of virology 64, 1002-1013.
Countryman, J., and Miller, G. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proceedings of the National Academy of Sciences of the United States of America 82, 4085-4089.
Crook, N.E., Clem, R.J., and Miller, L.K. (1993). An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. Journal of virology 67, 2168-2174.
Dambaugh, T., Hennessy, K., Chamnankit, L., and Kieff, E. (1984). U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proceedings of the National Academy of Sciences of the United States of America 81, 7632-7636.
Dreyfus, D.H., Nagasawa, M., Pratt, J.C., Kelleher, C.A., and Gelfand, E.W. (1999). Inactivation of NF-kappaB by EBV BZLF-1-encoded ZEBRA protein in human T cells. J Immunol 163, 6261-6268.
Epstein, M.A., Achong, B.G., and Barr, Y.M. (1964). Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet 1, 702-703.
Faggioni, A., Zompetta, C., Grimaldi, S., Barile, G., Frati, L., and Lazdins, J. (1986). Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science (New York, N.Y 232, 1554-1556.
Farrell, P.J., Rowe, D.T., Rooney, C.M., and Kouzarides, T. (1989). Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. The EMBO journal 8, 127-132.
Fixman, E.D., Hayward, G.S., and Hayward, S.D. (1995). Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. Journal of virology 69, 2998-3006.
Flemington, E., and Speck, S.H. (1990). Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. Journal of virology 64, 1227-1232.
Graham, F.L., Smiley, J., Russell, W.C., and Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. The Journal of general virology 36, 59-74.
Grossman, S.R., Johannsen, E., Tong, X., Yalamanchili, R., and Kieff, E. (1994). The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proceedings of the National Academy of Sciences of the United States of America 91, 7568-7572.
Hardwick, J.M., Lieberman, P.M., and Hayward, S.D. (1988). A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. Journal of virology 62, 2274-2284.
Hennessy, K., and Kieff, E. (1985). A second nuclear protein is encoded by Epstein-Barr virus in latent infection. Science (New York, N.Y 227, 1238-1240.
Hinuma, Y., Konn, M., Yamaguchi, J., Wudarski, D.J., Blakeslee, J.R., Jr., and Grace, J.T., Jr. (1967). Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. Journal of virology 1, 1045-1051.
Hoffman, W.H., Biade, S., Zilfou, J.T., Chen, J., and Murphy, M. (2002). Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. The Journal of biological chemistry 277, 3247-3257.
Hong, G.K., Gulley, M.L., Feng, W.H., Delecluse, H.J., Holley-Guthrie, E., and Kenney, S.C. (2005a). Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. Journal of virology 79, 13993-14003.
Hong, G.K., Kumar, P., Wang, L., Damania, B., Gulley, M.L., Delecluse, H.J., Polverini, P.J., and Kenney, S.C. (2005b). Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines. Journal of virology 79, 13984-13992.
Hsieh, J.J., and Hayward, S.D. (1995). Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. Science (New York, N.Y 268, 560-563.
Hsieh, J.J., Zhou, S., Chen, L., Young, D.B., and Hayward, S.D. (1999). CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proceedings of the National Academy of Sciences of the United States of America 96, 23-28.
Hu, S., and Yang, X. (2003). Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. The Journal of biological chemistry 278, 10055-10060.
Huang, Y., Park, Y.C., Rich, R.L., Segal, D., Myszka, D.G., and Wu, H. (2001). Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell 104, 781-790.
Hummel, M., Thorley-Lawson, D., and Kieff, E. (1984). An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200). Journal of virology 49, 413-417.
Jiang, Y., Saavedra, H.I., Holloway, M.P., Leone, G., and Altura, R.A. (2004). Aberrant regulation of survivin by the RB/E2F family of proteins. The Journal of biological chemistry 279, 40511-40520.
Jung, E.J., Lee, Y.M., Lee, B.L., Chang, M.S., and Kim, W.H. (2007). Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir. Cancer letters 247, 77-83.
Kaiser, C., Laux, G., Eick, D., Jochner, N., Bornkamm, G.W., and Kempkes, B. (1999). The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. Journal of virology 73, 4481-4484.
Kao, H.Y., Ordentlich, P., Koyano-Nakagawa, N., Tang, Z., Downes, M., Kintner, C.R., Evans, R.M., and Kadesch, T. (1998). A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes & development 12, 2269-2277.
Kawakami, H., Tomita, M., Matsuda, T., Ohta, T., Tanaka, Y., Fujii, M., Hatano, M., Tokuhisa, T., and Mori, N. (2005). Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax. International journal of cancer 115, 967-974.
Kikuta, H., Taguchi, Y., Tomizawa, K., Kojima, K., Kawamura, N., Ishizaka, A., Sakiyama, Y., Matsumoto, S., Imai, S., Kinoshita, T., and et al. (1988). Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333, 455-457.
Knutson, J.C. (1990). The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization. Journal of virology 64, 2530-2536.
Laherty, C.D., Hu, H.M., Opipari, A.W., Wang, F., and Dixit, V.M. (1992). The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. The Journal of biological chemistry 267, 24157-24160.
Li, F., and Altieri, D.C. (1999). Transcriptional analysis of human survivin gene expression. The Biochemical journal 344 Pt 2, 305-311.
Li, F., Ambrosini, G., Chu, E.Y., Plescia, J., Tognin, S., Marchisio, P.C., and Altieri, D.C. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584.
Li, F., and Brattain, M.G. (2006). Role of the Survivin gene in pathophysiology. The American journal of pathology 169, 1-11.
Lieberman, P.M., and Berk, A.J. (1991). The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction. Genes & development 5, 2441-2454.
Lin, C.T., Wong, C.I., Chan, W.Y., Tzung, K.W., Ho, J.K., Hsu, M.M., and Chuang, S.M. (1990). Establishment and characterization of two nasopharyngeal carcinoma cell lines. Laboratory investigation; a journal of technical methods and pathology 62, 713-724.
Lu, J., Chen, S.Y., Chua, H.H., Liu, Y.S., Huang, Y.T., Chang, Y., Chen, J.Y., Sheen, T.S., and Tsai, C.H. (2000). Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta. Journal of virology 74, 7391-7399.
Luka, J., Kallin, B., and Klein, G. (1979). Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94, 228-231.
Makarova, O., Kamberov, E., and Margolis, B. (2000). Generation of deletion and point mutations with one primer in a single cloning step. BioTechniques 29, 970-972.
Marusawa, H., Matsuzawa, S., Welsh, K., Zou, H., Armstrong, R., Tamm, I., and Reed, J.C. (2003). HBXIP functions as a cofactor of survivin in apoptosis suppression. The EMBO journal 22, 2729-2740.
Mauser, A., Holley-Guthrie, E., Zanation, A., Yarborough, W., Kaufmann, W., Klingelhutz, A., Seaman, W.T., and Kenney, S. (2002). The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. Journal of virology 76, 12543-12552.
Mikaelian, I., Drouet, E., Marechal, V., Denoyel, G., Nicolas, J.C., and Sergeant, A. (1993). The DNA-binding domain of two bZIP transcription factors, the Epstein-Barr virus switch gene product EB1 and Jun, is a bipartite nuclear targeting sequence. Journal of virology 67, 734-742.
Miller, G., Robinson, J., Heston, L., and Lipman, M. (1974). Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. Proceedings of the National Academy of Sciences of the United States of America 71, 4006-4010.
Morrison, T.E., Mauser, A., Klingelhutz, A., and Kenney, S.C. (2004). Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1. Journal of virology 78, 544-549.
Mueller-Lantzsch, N., Lenoir, G.M., Sauter, M., Takaki, K., Bechet, J.M., Kuklik-Roos, C., Wunderlich, D., and Bornkamm, G.W. (1985). Identification of the coding region for a second Epstein-Barr virus nuclear antigen (EBNA 2) by transfection of cloned DNA fragments. The EMBO journal 4, 1805-1811.
O'Connor, D.S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P.C., and Altieri, D.C. (2000). Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proceedings of the National Academy of Sciences of the United States of America 97, 13103-13107.
Rhim, J.S. (1989). Neoplastic transformation of human epithelial cells in vitro. Anticancer research 9, 1345-1365.
Riedl, S.J., Renatus, M., Schwarzenbacher, R., Zhou, Q., Sun, C., Fesik, S.W., Liddington, R.C., and Salvesen, G.S. (2001). Structural basis for the inhibition of caspase-3 by XIAP. Cell 104, 791-800.
Rowe, M., Peng-Pilon, M., Huen, D.S., Hardy, R., Croom-Carter, D., Lundgren, E., and Rickinson, A.B. (1994). Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers. Journal of virology 68, 5602-5612.
Salvesen, G.S., and Duckett, C.S. (2002). IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3, 401-410.
Schepers, A., Pich, D., and Hammerschmidt, W. (1993). A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. The EMBO journal 12, 3921-3929.
Schimmer, A.D. (2004). Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer research 64, 7183-7190.
Sinclair, A.J. (2003). bZIP proteins of human gammaherpesviruses. The Journal of general virology 84, 1941-1949.
Sixbey, J.W., Vesterinen, E.H., Nedrud, J.G., Raab-Traub, N., Walton, L.A., and Pagano, J.S. (1983). Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 306, 480-483.
Song, J., Salek-Ardakani, S., So, T., and Croft, M. (2007). The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes. Nature immunology 8, 64-73.
Song, Z., Yao, X., and Wu, M. (2003). Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. The Journal of biological chemistry 278, 23130-23140.
Speck, S.H., Chatila, T., and Flemington, E. (1997). Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends in microbiology 5, 399-405.
Stauber, R.H., Mann, W., and Knauer, S.K. (2007). Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer research 67, 5999-6002.
Stauber, R.H., Rabenhorst, U., Rekik, A., Engels, K., Bier, C., and Knauer, S.K. (2006). Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal. Traffic (Copenhagen, Denmark) 7, 1461-1472.
Sung, N.S., Kenney, S., Gutsch, D., and Pagano, J.S. (1991). EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. Journal of virology 65, 2164-2169.
Suzuki, A., Hayashida, M., Ito, T., Kawano, H., Nakano, T., Miura, M., Akahane, K., and Shiraki, K. (2000). Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene 19, 3225-3234.
Suzuki, Y., Nakabayashi, Y., and Takahashi, R. (2001). Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proceedings of the National Academy of Sciences of the United States of America 98, 8662-8667.
Tong, X., Drapkin, R., Reinberg, D., and Kieff, E. (1995a). The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2. Proceedings of the National Academy of Sciences of the United States of America 92, 3259-3263.
Tong, X., Drapkin, R., Yalamanchili, R., Mosialos, G., and Kieff, E. (1995b). The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Molecular and cellular biology 15, 4735-4744.
Tong, X., Wang, F., Thut, C.J., and Kieff, E. (1995c). The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. Journal of virology 69, 585-588.
Tovey, M.G., Lenoir, G., and Begon-Lours, J. (1978). Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276, 270-272.
Tu, S.P., Jiang, X.H., Lin, M.C., Cui, J.T., Yang, Y., Lum, C.T., Zou, B., Zhu, Y.B., Jiang, S.H., Wong, W.M., et al. (2003). Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer research 63, 7724-7732.
Vader, G., Medema, R.H., and Lens, S.M. (2006). The chromosomal passenger complex: guiding Aurora-B through mitosis. The Journal of cell biology 173, 833-837.
Vasef, M.A., Ferlito, A., and Weiss, L.M. (1997). Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus. The Annals of otology, rhinology, and laryngology 106, 348-356.
Wang, F., Gregory, C.D., Rowe, M., Rickinson, A.B., Wang, D., Birkenbach, M., Kikutani, H., Kishimoto, T., and Kieff, E. (1987). Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proceedings of the National Academy of Sciences of the United States of America 84, 3452-3456.
Weiss, L.M., Movahed, L.A., Warnke, R.A., and Sklar, J. (1989). Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. The New England journal of medicine 320, 502-506.
Wen, W., Iwakiri, D., Yamamoto, K., Maruo, S., Kanda, T., and Takada, K. (2007). Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. Journal of virology 81, 1037-1042.
Wheatley, S.P., Henzing, A.J., Dodson, H., Khaled, W., and Earnshaw, W.C. (2004). Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo. The Journal of biological chemistry 279, 5655-5660.
Woisetschlaeger, M., Yandava, C.N., Furmanski, L.A., Strominger, J.L., and Speck, S.H. (1990). Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 87, 1725-1729.
Xu, R., Zhang, P., Huang, J., Ge, S., Lu, J., and Qian, G. (2007). Sp1 and Sp3 regulate basal transcription of the survivin gene. Biochemical and biophysical research communications 356, 286-292.
Young, L.S., and Rickinson, A.B. (2004). Epstein-Barr virus: 40 years on. Nature reviews 4, 757-768.
Zhang, Q., Gutsch, D., and Kenney, S. (1994). Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Molecular and cellular biology 14, 1929-1938.
Zimber-Strobl, U., Kempkes, B., Marschall, G., Zeidler, R., Van Kooten, C., Banchereau, J., Bornkamm, G.W., and Hammerschmidt, W. (1996). Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. The EMBO journal 15, 7070-7078.
zur Hausen, H., O'Neill, F.J., Freese, U.K., and Hecker, E. (1978). Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272, 373-375.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26506-
dc.description.abstract摘要
Survivin是屬於IAP (inhibitor of apoptosis protein) 蛋白質家族的一員,此類蛋白質家族可以藉著直接結合Caspase而抑制其活性,藉此抑制細胞凋亡 (apoptosis) 的進行。近年來諸多研究指出Survivin也可以幫助細胞週期 (cell cycle) 的進行與染色體的分裂。除此之外,Survivin已經被認為是非常重要的腫瘤標誌物 (tumor marker),因其高度表現於快速增生的細胞,而不表現在分化完全的成人細胞,甚至幾乎所有的癌細胞都可以偵測到Survivin大量的表現。在先前實驗室研究中觀察到與EB病毒高度相關的鼻咽癌 (NPC) 和移植後淋巴增殖性疾病 (PTLD) 的組織切片,Survivin均有大量表現的現象,同樣在EB病毒感染B細胞後也能觀察到Survivin高度表現的現象。然而EB病毒究竟如何調控Survivin表現,則目前並不清楚,因此於本研究我們嚐試探索EB病毒調控Survivin的機轉。實驗中利用反轉錄聚合酶鏈反應 (RT-PCR) 與西方墨點法 (Western blotting),我們發現EB病毒所表現的轉錄活化子,Zta和EBNA2可以增加Survivin mRNA與蛋白質的表現。除此之外,我們也證明Zta與EBNA2可以藉由活化Survivin啟動子增加Survivin的表現。而利用報導者分析法 (reporter assay),我們發現Survivin啟動子上對於Zta調控Survivin啟動子重要的片段,並且在電泳位移分析法 (EMSA) 的實驗也證明Zta可結合Survivin啟動子上的ZRE (Zta response element),這些結果指出Zta可能是透過結合至Survivin啟動子上的ZRE活化Survivin的啟動子。此外我們藉由細胞核質分離法 (Subcellular fractionation) 發現Zta所增加的Survivin主要表現在細胞核裡,目前已知當Survivin大量表現在細胞核裡可以幫助細胞週期的進行與細胞的增生。而在[3H]胸腺嘧啶嵌入法實驗中我們也發現,表現Zta的細胞其生長速率較控制組細胞迅速。但是當我們利用siRNA的技術抑制Survivin的表現後,即使細胞表現Zta也無法幫助細胞增生,此結果顯示Zta可藉由增加Survivin表現促進細胞的增生。
zh_TW
dc.description.abstractAbstract
Survivin is a member of IAP (inhibitor of apoptosis protein) protein family, which can inhibit apoptosis by directly binding and blocking activity of caspases. Recently, several studies reported that Survivn can promote cell cycle progression and sister chromatids segregation. Additionally, Survivin has been identified as a potential tumor marker, since it selectively overexpressed in most of cancer cells but not in normal cells. Previously, we found that Survivin was overespressed in nasopharygenal carcinoma (NPC) and in post-transplanted lymphoproliferative disease (PTLD) biopsies, and that overexpression of Survivin is highly associated with Epstein-Barr virus (EBV) infection. However, the mechanism of how EBV regulates Survivin expression is still unclear. Thus, we sought to investigate the mechanism of EBV regulates expression of Survivin. To aim this, several EBV viral proteins, including latent and lytic proteins, were transfected into 293 cells, and subjected to RT-PCR and western blotting to investigate their effects on the expression of Survivin. Two EBV viral transactivators, Zta and EBNA2 were found to enhance Survivin expresision in mRNA and protein levels. In addition, Zta and EBNA2 can activate Survivin promoter in luciferase reporter assay. Furthermore, we defined the crucial domain for Zta-mediated Suvivin promoter activity by luciferase reporter assay and demonstrated that Zta can directly bind to the Zta responsive element (ZRE) embeded in Survivin promoter by EMSA. These results suggest that Zta may upregulate Survivin expression through directly enhancing Survivin promoter activity. Of note, we found that Zta can specifically upregulate Survivin in the nuclear portion by subcellular fractionation assay, which is the sign for Survivin to promote G1/S phase progression and cell proliferation. Accordingly, we found that Zta can enhance cell proliferation rate in [3H]-thymidine incorporation assay. And, when we knocked down Survivin expression by siRNA (small interference RNA), This Zta-induced cell proliferation could be disrupted by Survivin siRNA. The results indicate that Zta can enhance cell proliferation via increasing Survivin expression.
en
dc.description.provenanceMade available in DSpace on 2021-06-08T07:12:54Z (GMT). No. of bitstreams: 1
ntu-97-R95445124-1.pdf: 1955532 bytes, checksum: b3fb980f6e5d5c68de24820e1b64ce42 (MD5)
Previous issue date: 2008
en
dc.description.tableofcontents誌謝………………………………………………………………………I
中文摘要……………………………………………………………II
英文摘要………………………………………………………………III
序論………………………………………………………………………1
實驗動機…………………………………………………………12
實驗方法與材料………………………………………………………13
實驗結果………………………………………………………22
討論…………………………………………………………………29
圖表…………………………………………………………………34
參考文獻……………………………………………………………58
dc.language.isozh-TW
dc.subjectSurvivinzh_TW
dc.subjectztazh_TW
dc.titleEB病毒蛋白質Zta與EBNA2調控Survivin表現之探究zh_TW
dc.titleRegulation of Survivin by Epstein-Barr viral proteins, Zta and EBNA2en
dc.typeThesis
dc.date.schoolyear96-2
dc.description.degree碩士
dc.contributor.oralexamcommittee許翠瑛(Tsuey-Ying Hsu),呂仁(Lu , Jean),羅?升(Wan-Sheng Lo)
dc.subject.keywordzta,Survivin,zh_TW
dc.relation.page66
dc.rights.note未授權
dc.date.accepted2008-07-31
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept微生物學研究所zh_TW
顯示於系所單位:微生物學科所

文件中的檔案:
檔案 大小格式 
ntu-97-1.pdf
  未授權公開取用
1.91 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved